The Department of Health and Social Care and MHRA are amending the Human Medicines Regulations through draft regulations and consultation on changes to health service product information disclosure rules, aimed at benefiting NHS patients and British businesses through modernised medicines access procedures. The amendments represent significant changes to the regulatory framework governing medicines approval and provision.
Seeks views on proposed amendments to the Health Service Products (Provision and Disclosure of Information) Regulations 2018.
In response to: Using dual energy x-ray absorptiometry (DEXA) scans for non-medical purposes as a justifi…
To ask the Secretary of State for Health and Social Care, if he will publish any of the pre-clinical data, study reports or assessments made by the Medicines and Healthcare products Regulatory Agency (MHRA) that the MHRA’s Chief Safety Officer …
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his Department's policies of the increasing percentage of funding for the World Health Organization coming from (a) specified and …
To ask the Secretary of State for Health and Social Care, if he will publish the most recent Medicines and Healthcare products Regulatory Agency (MHRA) pharmacovigilance assessment or signal evaluation report that specifically addresses potential cancer/n
To ask the Secretary of State for Health and Social Care, if he will work towards a mutual recognition agreement with India on medicines regulation by 2030.
To ask the Secretary of State for Health and Social Care, whether external organisations, including charities and patient organisations, will have opportunities to submit written evidence to any review of meningococcal group B vaccines or meningococcal gr
To ask the Secretary of State for Health and Social Care, that the recognition of air ambulance services within NHS emergency services fuel access arrangements is safeguarded and maintained, ensuring priority access in line with other frontline emergency
To ask His Majesty's Government what steps they are taking to secure supplies of medicines, medical devices and medical consumables in the case of war or pandemic; and whether those steps include building and maintaining strategic reserves of those suppli
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the Chief Executive of the NHS Business Services Authority on the operation of the Vaccine Damage Payment Scheme.
To ask the Secretary of State for Health and Social Care, what plans he has to publish an implementation timetable for the regulations under the Tobacco and Vapes Bill.
To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, pub
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the US CLOUD Act on the security of NHS patient data held or processed by US-based companies; and whether …
To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, pub
To ask the Secretary of State for Health and Social Care, what information his Department holds on where licenced donor animal blood is sourced from to develop animal blood-enriched agar for use across the NHS; and if he will make …
To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, pub
We are seeking views on the potential use of DEXA scans outside of a healthcare pathway.
In response to: Proposed changes to the health service products information regulations 2018
Seeks views on proposed amendments to the Health Service Products (Provision and Disclosure of Information) Regulations 2018.
In response to: Amend regulations to support the supply and deployment of vaccines
In response to: Amend regulations to support the supply and deployment of vaccines
This consultation seeks views on amending the Human Medicines Regulations 2012 to support the ongoing supply and deployment of vaccinations across the UK.
This consultation seeks views on proposals to enable pharmacist flexibilities when dispensing medicines.
This consultation seeks views on amending the Human Medicines Regulations 2012 to support the ongoing supply and deployment of vaccinations across the UK.
This consultation seeks views on extending medicines responsibilities for paramedics, physiotherapists, operating department practitioners and diagnostic radiographers.
This consultation seeks views on proposals to enable pharmacist flexibilities when dispensing medicines.
This consultation seeks views on amending the Human Medicines Regulations 2012 to support the ongoing supply and deployment of vaccinations across the UK.
In response to: Extend medicines for optometrists and contact lens opticians
This consultation seeks views on extending medicines responsibilities for paramedics, physiotherapists, operating department practitioners and diagnostic radiographers.
In response to: Extend medicines responsibilities for allied health professions
DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy.
UIN: HCWS818 I would like to update the House that the UK Government has accepted the amendments to the International Health Regulations (2005) (IHR) which were agreed by countries at the World Health Assembly (WHA) on 1 June 2024.The IHRs …
UIN: HLWS818 My hon. Friend the Parliamentary Under-Secretary of State for Public Health and Prevention (Ashley Dalton MP) made the following Statement:I would like to update the House that the UK Government has accepted the amendments to the International Health …
In response to: Health Protection (Notification) Regulations 2010: proposed amendments
UIN: HCWS310 My noble friend the Parliamentary Under-Secretary of State for Patient Safety, Women's Health and Mental Health (Baroness Merron) has made the following Written StatementI am pleased to announce that the Medicines for Human Use (Clinical Trials) (Amendmen...
UIN: HLWS306 I am pleased to announce that the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 have been laid before Parliament today. When approved by Parliament, this legislation will represent the most significant reform of UK clinical trials...
This consultation seeks views on proposed amendments to the Health Protection (Notification) Regulations 2010 (HPNR).
To ask the Secretary of State for Health and Social Care, what his policy is on (a) doctors and (b) other qualified medical personnel administering pain-relieving drugs which may shorten lives; and whether regulations on that issue changed after the …
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of making Tranexamic Acid (TXA) a Schedule 19 Drug. Answer: Discussions on the administration of tranexamic acid (TXA) formed part …
UIN: HCWS152 I am pleased to announce that the draft Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024 were laid before Parliament yesterday. When approved by Parliament, this instrument will create a new regulatory framework for inn...
UIN: HLWS149 My Hon. Friend the Minister of State for Health (Secondary Care) (Karin Smyth MP) has made the following Written Statement: I am pleased to announce that the draft Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations …
UIN: HCWS467 In a parliamentary debate on 23 October 2023, I announced the Government’s intention to update the UK’s gamete donation regulations. The first change would allow people living with HIV with an undetectable viral load to donate their gametes. …
In response to: Amending references to PHE and HSCB in the Human Medicines Regulations
In response to: Amending references to PHE and HSCB in the Human Medicines Regulations
We are seeking views about making amendments to references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012.
This consultation will inform the government’s proposal to enable pharmacy technicians to supply and administer medicines using patient group directions.
In response to: Framework agreement between DHSC and the Medicines and Healthcare products Regulatory Age…
Describes the working relationship between the Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency.
DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy.
We are seeking views about making amendments to references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012.
We are seeking views about making amendments to references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012.
This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).
DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy.
This consultation seeks views on proposed amendments to the Health Protection (Notification) Regulations 2010 (HPNR).
This consultation will inform the government’s proposal to enable pharmacy technicians to supply and administer medicines using patient group directions.
This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).
This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).
This consultation will inform the government’s proposal to enable pharmacy technicians to supply and administer medicines using patient group directions.
This consultation seeks views on proposed amendments to the Health Protection (Notification) Regulations 2010 (HPNR).
The government's summary of an EU Commission proposal to amend EU legislation relating to medicinal products for human use and the impact on Northern Ireland.
The government's summary of a EU Commission proposal to amend EU legislation relating to medicinal products for human use and the impact on Northern Ireland.
UIN: HLWS867 My Hon Friend the Parliamentary Under Secretary of State (Minister for Primary Care and Public Health) (Neil O’Brien) has made the following written statement:I have today published the draft Statutory Instrument: The Public Health England (Dissolution) (...
UIN: HCWS882 I have today published the draft Statutory Instrument: The Public Health England (Dissolution) (Consequential Amendments) Regulations 2023 and accompanying Explanatory Memorandum.This statutory instrument (SI) amends other regulations in consequence of th...
The government's summary of a European Commission proposal on fees and charges payable to the European Medicines Agency.
Public consultation on proposals to allow pharmacists to dispense prescription medicines in original packaging, in particular those containing sodium valproate.
In response to: Point of Care Consultation
UIN: HLWS476 My Rt Hon Friend the Secretary of State for Health and Social Care (Steve Barclay) has made the following written statement: The UK’s response to the COVID-19 pandemic demonstrated the power of Government collaborating with industry to accelerate …
UIN: HLWS475 My Rt Hon Friend the Secretary of State for Health and Social Care (Steve Barclay) has made the following written statement: The COVID-19 pandemic has shown the importance of having the ability to develop and deploy vaccines rapidly …
In response to: The future strategy for batch testing of medicinal products in Great Britain
In response to: The future strategy for batch testing of medicinal products in Great Britain
We want your views on 4 proposed options for a future policy on batch testing of medicines for Great Britain.
We want your views on 4 proposed options for a future policy on batch testing of medicines for Great Britain.
UIN: HLWS129 My Rt Hon Friend the Secretary of State for Health and Social Care (Sajid Javid) has made the following written statement:The life sciences have played an essential role in helping us to learn to live with COVID-19. The …
We want your views on 4 proposed options for a future policy on batch testing of medicines for Great Britain.
In response to: Pharmacy legislation on dispensing errors and organisational governance
Seeks views on proposals for 2 draft orders which would amend current pharmacy legislation on dispensing errors and clarify how registered pharmacies are governed.
In response to: Tobacco and related products legislation introduced between 2015 and 2016: reviewing effe…
The government's summary of an EU regulation about protein requirements for infant and follow-on formula manufactured from protein hydrolysates.
In response to: Early Access to Medicines Scheme (EAMS) Consultation
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.
In response to: Review of temporary provisions in the Human Medicines Regulations 2012 to support influen…
In response to: Review of temporary provisions in the Human Medicines Regulations 2012 to support influen…
In response to: Review of temporary provisions in the Human Medicines Regulations 2012 to support influen…
We would like your views on a review of temporary provisions in the Human Medicines Regulations to support influenza and COVID-19 vaccination campaigns.
We would like your views on a review of temporary provisions in the Human Medicines Regulations to support influenza and COVID-19 vaccination campaigns.
UIN: HCWS507 Under the Northern Ireland Protocol (NIP), medicines moving from GB to NI are required to comply with the EU Pharmaceutical Acquis. This creates a number of additional and duplicative regulatory barriers which risk the continuity of supply for …
UIN: HLWS494 My Hon Friend the Minister of State for Health (Edward Argar) has made the following statement:Under the Northern Ireland Protocol (NIP), medicines moving from GB to NI are required to comply with the EU Pharmaceutical Acquis. This creates …
Public consultation on proposals to allow pharmacists to dispense prescription medicines in original packaging, in particular those containing sodium valproate.
We would like your views on a review of temporary provisions in the Human Medicines Regulations to support influenza and COVID-19 vaccination campaigns.
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
Public consultation on proposals to allow pharmacists to dispense prescription medicines in original packaging, in particular those containing sodium valproate.
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.
We're looking for your views and comments on our proposed legislative changes to clarify the legal basis for EAMS.
UIN: HLWS92 My Hon. Friend the Parliamentary Under Secretary of State (Minister for Prevention, Public Health and Primary Care) (Jo Churchill) has made the following written statement:Testing will remain important to controlling and containing the virus going forward...
UIN: HCWS734 I would like to update the House on progress made by the Department of Health and Social Care towards ensuring patients can continue to access Bedrocan cannabis oils from the Netherlands.The UK has left the EU, and the …
UIN: HLWS516 My Hon Friend the Parliamentary Under Secretary of State (Minister for Prevention, Public Health and Primary Care) (Jo Churchill) has made the following written statement:The primary objective of our policy is to support the expansion of the annual …
UIN: HCWS520 The primary objective of our policy is to support the expansion of the annual seasonal flu vaccination campaign and to support the successful roll-out of a safe and effective COVID-19 vaccine. Throughout the Coronavirus outbreak, the government has …
UIN: HLWS340 My Hon Friend the Minister of State (Minister for Patient Safety, Suicide Prevention and Mental Health) (Nadine Dorries) has made the following written statement:I am today informing the House of the publication of the report of the Independent …
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
There is no evidence from clinical or epidemiological studies that treatment with ACE-I or ARBs might worsen COVID-19 infection.
This consultation seeks your views on how the Medicines and Healthcare products Regulatory Agency’s (MHRA) legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s …
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
This consultation seeks your views on how the Medicines and Healthcare products Regulatory Agency’s (MHRA) legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s …
This consultation seeks your views on how the Medicines and Healthcare products Regulatory Agency’s (MHRA) legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s …
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
Seeks views on proposals for 2 draft orders which would amend current pharmacy legislation on dispensing errors and clarify how registered pharmacies are governed.
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
Seeks views on proposals for 2 draft orders which would amend current pharmacy legislation on dispensing errors and clarify how registered pharmacies are governed.
We are reviewing the impact of the Human Medicines Regulations 2012 (‘the 2012 Regulations’). This is part of a wider exercise within government to test the impact of legislation five years after implementation.
Seeks views on proposals for changes to the legislation on dispensing errors and registered pharmacy standards and other related matters.
We are reviewing the impact of the Human Medicines Regulations 2012 (‘the 2012 Regulations’). This is part of a wider exercise within government to test the impact of legislation five years after implementation.
We are reviewing the impact of the Human Medicines Regulations 2012 (‘the 2012 Regulations’). This is part of a wider exercise within government to test the impact of legislation five years after implementation.
Seeks views on draft regulations on implementing the revised EU Tobacco Products Directive (2014/40/EU).
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
Seeks views on draft regulations on implementing the revised EU Tobacco Products Directive (2014/40/EU).
Seeks views on the role and performance of the Medicines and Healthcare Products Regulatory Agency (MHRA)
Seeks views on draft regulations on implementing the revised EU Tobacco Products Directive (2014/40/EU).
Seeks views on proposals for changes to the legislation on dispensing errors and registered pharmacy standards and other related matters.
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
Seeks views on proposals for changes to the legislation on dispensing errors and registered pharmacy standards and other related matters.
Seeks views on proposals to amend the Human Medicines Regulations 2012 so that PHE can develop and authorise Patient Group Directions.
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
Seeks views on the role and performance of the Medicines and Healthcare Products Regulatory Agency (MHRA)
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
Seeks views on the role and performance of the Medicines and Healthcare Products Regulatory Agency (MHRA)
Seeks views on proposals to amend the Human Medicines Regulations 2012 so that PHE can develop and authorise Patient Group Directions.
Seeks views on proposals to amend the Human Medicines Regulations 2012 so that PHE can develop and authorise Patient Group Directions.
This consultation welcomes views on proposals to allow paramedics involved in maritime and coastguard agency contracted helicopter search and rescue operations to use medicines under patient group directions.
This consultation welcomes views on proposals to allow paramedics involved in maritime and coastguard agency contracted helicopter search and rescue operations to use medicines under patient group directions.
Second Reading 11:22:00 Moved by Lord Winston: That the Bill be read a second time. Lord Winston (Lab): My Lords, first, I am so pleased to see the noble Baroness sitting on the Front Bench, but so sad that the …
First Reading 15:07:00 A Bill to require the declaration relating to animal research to be placed on medicinal products’ labels. The Bill was introduced by Lord Winston, read a first time and ordered to be printed.